|
Dr. Denis Garceau directs Neurochem's Drug Development program, from toxicology to regulatory submissions and clinical evaluation through to approval of new products, and has been with the Company since March 1997. As a clinical scientist and Product Team Leader for Hoechst Marion Roussel, Dr. Garceau successfully oversaw North American clinical programs and participated in global clinical development steering committees. Dr. Garceau was responsible for developing clinical operating plans, designing clinical protocols, and supervising clinical trials. Dr. Garceau holds a Ph.D in Pharmacology from the Université de Montréal, where he is currently a guest lecturer (Pharmacology) for the Faculty of Pharmacy. | 